Yilmaz Mahshid
Vermogen: 201 662 $ op 31-05-2026
Vermogen: 201 662 $ op 31-05-2026
Dr. Yilmaz Mahshid is a Chief Financial Officer at Egetis Therapeutics AB and an Independent Director at InDex Pharmaceuticals AB. He is on the Board of Directors at Medivir AB, InDex Pharmaceuticals AB and Mahshid Advisors AB. Dr. Mahshid was previously employed as an Investment Manager & Controller by Industrifonden, a Research Analyst by Pareto Securities AB, a Research Analyst by Pareto Öhman AB, and a Research Analyst by E.
Öhman J:or Fondkommission AB. He also served on the board at Flerie AB, Avidicare AB and Venaticus Capital AB. He received his doctorate degree from Karolinska Institutet.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-05-2026 | 306.249 ( 0,07% ) | 201 662 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MEDIVIR AB | Directeur/Bestuurslid | 05-05-2021 |
| EGETIS THERAPEUTICS AB | Financieel Directeur/CFO | 01-06-2021 |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Bestuurslid | 01-04-2020 |
Mahshid Advisors AB | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Venaticus Capital AB | Directeur/Bestuurslid | 18-03-2022 |
| EGETIS THERAPEUTICS AB | Financieel Directeur/CFO | 01-09-2020 |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden invests in companies located in the Nordic region. The firm targets companies operating in the fields of planetary health, life science, deep tech and transformative tech. It provides financing for seed and early stage capital requirements with an investment size of SEK 10 – 50 million. | Comptroller/Controller/Auditor | 30-11-2017 |
Pareto Securities AB
Pareto Securities AB Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01-05-2015 |
Pareto Öhman AB
Pareto Öhman AB Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 18-09-2013 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 12 |
|---|---|
Medivir AB
Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden invests in companies located in the Nordic region. The firm targets companies operating in the fields of planetary health, life science, deep tech and transformative tech. It provides financing for seed and early stage capital requirements with an investment size of SEK 10 – 50 million. | Finance |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
E. Öhman J:or Fondkommission AB
E. Öhman J:or Fondkommission AB Financial ConglomeratesFinance Operates as a capital management company | Finance |
Flerie AB
Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
Egetis Therapeutics AB
Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Pareto Öhman AB
Pareto Öhman AB Investment Banks/BrokersFinance Provides brokerage services | Finance |
Pareto Securities AB
Pareto Securities AB Investment Banks/BrokersFinance Provides brokerage services | Finance |
Avidicare AB
Avidicare AB Medical DistributorsDistribution Services Provides products that reduces airborne bacteria and virus pollution at hospitals. | Distribution Services |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Venaticus Capital AB | |
Mahshid Advisors AB |
Kies jouw editie
Alle financiële informatie op nationaal niveau